» Articles » PMID: 27768863

Choroidal Involution Is Associated with a Progressive Degeneration of the Outer Retinal Function in a Model of Retinopathy of Prematurity: Early Role for IL-1β

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2016 Oct 22
PMID 27768863
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Retinopathy of prematurity (ROP), the most common cause of blindness in premature infants, has long been associated with inner retinal alterations. However, recent studies reveal outer retinal dysfunctions in patients formerly afflicted with ROP. We have recently demonstrated that choroidal involution occurs early in retinopathy. Herein, we investigated the mechanisms underlying the choroidal involution and its long-term impact on retinal function. An oxygen-induced retinopathy (OIR) model was used. In vitro and ex vivo assays were applied to evaluate cytotoxic effects of IL-1β on choroidal endothelium. Electroretinogram was used to evaluate visual function. We found that proinflammatory IL-1β was markedly increased in retinal pigment epithelium (RPE)/choroid and positively correlated with choroidal degeneration in the early stages of retinopathy. IL-1β was found to be cytotoxic to choroid in vitro, ex vivo, and in vivo. Long-term effects on choroidal involution included a hypoxic outer neuroretina, associated with a progressive loss of RPE and photoreceptors, and visual deterioration. Early inhibition of IL-1β receptor preserved choroid, decreased subretinal hypoxia, and prevented RPE/photoreceptor death, resulting in life-long improved visual function in IL-1 receptor antagonist-treated OIR animals. Together, these findings suggest a critical role for IL-1β-induced choroidal degeneration in outer retinal dysfunction. Neonatal therapy using IL-1 receptor antagonist preserves choroid and prevents protracted outer neuroretinal anomalies in OIR, suggesting IL-1β as a potential therapeutic target in ROP.

Citing Articles

Age-Related Choroidal Involution Is Associated with the Senescence of Endothelial Progenitor Cells in the Choroid.

Nazari A, Gresseau L, Habelrih T, Zia A, Lahaie I, Er-Reguyeg Y Biomedicines. 2025; 12(12.

PMID: 39767576 PMC: 11726740. DOI: 10.3390/biomedicines12122669.


The Impact of (rs10490924), (rs3024997), (rs1061622), (rs4149576), and (rs1143623) Polymorphisms and Serum Levels on Age-Related Macular Degeneration Development and Therapeutic Responses.

Cebatoriene D, Vilkeviciute A, Gedvilaite-Vaicechauskiene G, Duseikaite M, Bruzaite A, Kriauciuniene L Int J Mol Sci. 2024; 25(17).

PMID: 39273697 PMC: 11396313. DOI: 10.3390/ijms25179750.


Retinopathy of Prematurity-Targeting Hypoxic and Redox Signaling Pathways.

Zhang L, Buonfiglio F, Fiess A, Pfeiffer N, Gericke A Antioxidants (Basel). 2024; 13(2).

PMID: 38397746 PMC: 10885953. DOI: 10.3390/antiox13020148.


measurement of mitochondrial ROS production in mouse models of photoreceptor degeneration.

Menger K, Logan A, Luhmann U, Smith A, Wright A, Ali R Redox Biochem Chem. 2023; 5-6:None.

PMID: 38046619 PMC: 10686909. DOI: 10.1016/j.rbc.2023.100007.


The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern.

Sun W, An X, Zhang Y, Zhao X, Sun Y, Yang C Front Endocrinol (Lausanne). 2023; 14:1270145.

PMID: 38027131 PMC: 10680169. DOI: 10.3389/fendo.2023.1270145.